Poseida pitches a $115M IPO on its claim that the science team has created a better BCMA CAR-T

Poseida pitches a $115M IPO on its claim that the science team has created a better BCMA CAR-T

Submitted by admin on January 6, 2019 - 1:58pm
Source: 
Endpoints
News Tags: 
Poseida Therapeutics
IPOs
BCMA
CAR-T
Headline: 
Poseida pitches a $115M IPO on its claim that the science team has created a better BCMA CAR-T
snippet: 


Is there enough enthusiasm among biotech investors to push through a $115 million-plus IPO on the latest biotech staking out their claim with a new-and-improved BCMA CAR-T therapy?

Do Not Allow Advertisers to Use My Personal information